Cargando…

Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis

(1) Background: The objective of this rapid review is to assess whether new potassium binders (NPBs) could enable the optimization of RAASi therapy more than usual care or placebo in patients with or at risk of heart failure and hyperkalemia. (2) Methods: We searched for RCTs that included patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montagnani, Andrea, Frasson, Stefania, Gussoni, Gualberto, Manfellotto, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658658/ https://www.ncbi.nlm.nih.gov/pubmed/34884184 http://dx.doi.org/10.3390/jcm10235483

Ejemplares similares

Comment on Montagnani et al. Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis. J. Clin. Med. 2021, 10, 5483
por: Zarzuela, Donna, et al.
Publicado: (2022)

Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
por: Silva-Cardoso, José, et al.
Publicado: (2021)

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
por: Kanda, Eiichiro, et al.
Publicado: (2023)

Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease
por: Santoro, Antonio, et al.
Publicado: (2021)

Optimizing Therapies in Heart Failure: The Role of Potassium Binders
por: Scicchitano, Pietro, et al.
Publicado: (2022)

A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
por: Cañas, Alejandro E., et al.
Publicado: (2023)

RAASi Therapy Attenuates the Association between 24-h Urinary Potassium Excretion and Dietary Potassium Intake in CKD Patients
por: Giannese, Domenico, et al.
Publicado: (2023)

Selective potassium uptake via biocompatible zeolite–polymer hybrid microbeads as promising binders for hyperkalemia
por: Wang, Zhoujun, et al.
Publicado: (2020)

Hyperkalemia in heart failure
por: Sidhu, Kiran, et al.
Publicado: (2020)

Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients
por: Desai, Nihar R., et al.
Publicado: (2019)

Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial( )
por: Packer, Milton
Publicado: (2022)

Hyperkalemia in heart failure: Foe or friend?
por: Rakisheva, Amina, et al.
Publicado: (2020)

Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study)
por: Bjune, Thea, et al.
Publicado: (2023)

Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders
por: Hida, Yuki, et al.
Publicado: (2023)

Hyperkalemia caused by rapid red cell transfusion and the potassium absorption filter
por: Imashuku, Yasuhiko, et al.
Publicado: (2017)

Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study) [Corrigendum]
Publicado: (2023)

Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2023)

The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease
por: Evans, Marc, et al.
Publicado: (2019)

Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments
por: Zannad, Faiez, et al.
Publicado: (2019)

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
por: Esteban‐Fernández, Alberto, et al.
Publicado: (2022)

Hyperkalemia in Heart Failure: Probably Not O“K”
por: Fudim, Marat, et al.
Publicado: (2018)

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015)

A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure
por: Ward, Thomas, et al.
Publicado: (2023)

Piecing Together the Potassium Puzzle: The Weak Association Between Dietary Potassium and Hyperkalemia
por: Joshi, Shivam, et al.
Publicado: (2023)

The Colon as the Potassium Target: Entering the Colonic Age of Hyperkalemia Treatment?
por: Batlle, Daniel, et al.
Publicado: (2015)

Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020)

Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate
por: Oshima, Akira, et al.
Publicado: (2021)

Pharmacodynamic effects of the K(+) binder patiromer in a novel chronic hyperkalemia model in spontaneously hypertensive rats
por: Iyer, Sai Prasad N., et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018)

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial( )
por: Butler, Javed, et al.
Publicado: (2022)

Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study
por: Lopez-López, Andrea, et al.
Publicado: (2023)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

Impact of Plasma Potassium Normalization on Short‐Term Mortality in Patients With Hypertension and Hyperkalemia
por: Krogager, Maria Lukács, et al.
Publicado: (2020)

COVID-19 pandemic and Internal Medicine Units in Italy: a precious effort on the front line
por: Montagnani, Andrea, et al.
Publicado: (2020)

Chronic renal failure, hyperkalemia, and colonic ulcers
por: George, S. A., et al.
Publicado: (2014)

Hematochezia in a Patient with Renal Failure and Hyperkalemia
por: Meira, Tânia, et al.
Publicado: (2015)

Evaluating the Utility of Rapid Point-of-Care Potassium Testing for the Early Identification of Hyperkalemia in Patients with Chronic Kidney Disease in the Emergency Department
por: You, Je Sung, et al.
Publicado: (2014)

Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_956btkerssvkc6pb9dqq2t63bd